Skip to main content
. 2024 Feb 23;62(4):e00313-23. doi: 10.1128/jcm.00313-23

TABLE 1.

Sample types and testing for diagnosis of congenital and maternal CMV infectiona

Sample type Method Timing of evaluation Sens/Spec Comments References
Diagnosis of maternal primary CMV infection
 Serum Serology: CMV IgG <16 weeks’ gestation 97%–100%/96%–100%
  • Demonstration of seroconversion (IgG negative to positive) is definitive of primary infection

(10)
CMV IgM 54%–100%/62%–100%
  • IgM should not be used alone for diagnosis of primary infection due to poor sensitivity and specificity

(1017)
CMV IgG avidity 85%/>90%
  • For IgM- and IgG-positive samples, avidity is needed to determine recent primary infection

(18, 19)
Diagnosis of congenital CMV in the fetus
 Amniotic fluid NAAT 6 weeks after maternal infection
>21 weeks’ gestation
90%–95%/99%
  • Recommended sample type for diagnosis of fetal infection

(8, 20)
 Chorionic villi, umbilical cord blood NAAT NA ND
  • Alternate sample type for diagnosis of fetal infection

  • Not recommended due to increased risk to fetus during sample collection

(2123)
Diagnosis of congenital CMV in infant or older child
 Urine NAAT <3 weeks old 98.8%–100.0%/99%
  • Most specific sample for diagnosis in neonatal period

  • More difficult to collect than saliva

  • Should be confirmed by testing a new sample (urine or saliva) collected for >3 weeks of life.

(24, 25)
 Saliva NAAT <3 weeks old 97.4%–100.0%/91.5%–99.9%
  • Lacks specificity for diagnosis in the neonatal period due to contamination by breast milk

  • Easy to obtain so used as screening sample

  • Collect 1–2 h after breastfeeding

  • Must be confirmed if positive by testing a new sample (urine or saliva) collected >3 weeks of life.

(26, 27)
 Dried blood spotb NAAT >3 weeks old 34.4%–76.8%/99.9%
  • Used for retrospective diagnosis of congenital CMV

  • Sensitivity lower than urine or saliva

  • Negative result does not rule out congenital CMV

(28, 29)
 Blood, viral load NAAT <3 weeks old ND
  • Not recommended for screening for congenital CMV

  • Low sensitivity: 10%–20% of congenitally infected CMV infants are positive

  • If detected in blood, diagnostic for congenital CMV

  • Has limited use to monitor therapy

(26, 30)
 Serum Serology
CMV IgG
CMV IgM
NA ND
  • Not helpful in diagnosis of congenital CMV

  • Maternal IgG detectable for up to 6–12 months

  • Not useful due to lack of sensitivity and specificity

(31, 32)
a

NA, not available; NAAT, nucleic acid amplification testing; ND, not detected; Sens, sensitivity; Spec, specificity.

b

Sample collected at birth.